RPA-CRISRP/Cas12a技术快速检测实验动物感染肺炎克雷伯杆菌方法的建立及应用
Establishment and Application of RPA-CRISRP/Cas12aTechnology for Rapid Detection of Klebsiella pneumoniae Infection in Laboratory Animals
DOI: 10.12677/hjbm.2025.154087, PDF,    科研立项经费支持
作者: 魏 迅, 张 曼, 彭丽娜*:上海交通大学实验动物中心,上海
关键词: RPACRISPR/Cas12a肺炎克雷伯杆菌快速检测RPA CRISPR/Cas12a Klebsiella pneumoniae Rapid Detection
摘要: 目的:将RPA扩增技术与CRISPR/Cas12a检测技术相融合,建立实时、灵敏、特异的检测肺炎克雷伯杆菌的快速方法。方法:根据肺炎克雷伯杆菌phoE基因保守序列设计并合成特异性的RPA扩增引物和CRISPR RNA (crRNA),通过RPA等温扩增技术放大待测靶标基因,利用Cas12a蛋白的反式切割(trans-cleavage)活性检测靶标基因。对RPA-CRISPR/Cas12a检测体系的主要参数进行优化,确定最佳反应体系。结果:成功筛选出RPA扩增引物和crRNA,优化了体系中三个重要参数的最佳反应浓度crRNA (40 uM)、Cas12a (250 nM)和ssDNA (10 uM)。肺炎克雷伯杆菌基因组DNA检测灵敏度可达105 ng/uL,与实验动物常见的致病菌无交叉反应。该方法应用于实验动物临床检测时,具有较高的灵敏度和特异性。结论:本研究建立的RPA-CRISRP/Cas12a检测方法,操作简便、实时快速、成本低且特异性好,能够实现对实验动物感染肺炎克雷伯杆菌的快速检测。
Abstract: Objective: To integrate RPA amplification technology with CRISPR/Cas12a detection technology and establish a real-time, sensitive and specific rapid method for the detection of Klebsiella pneumoniae. Methods: Specific RPA amplification primers and CRISPR RNA (crRNA) were designed and synthesized based on the conserved sequence of the phoE gene of Klebsiella pneumoniae. The target gene to be tested was amplified by RPA isothermal amplification technology, and the trans cleavage activity of Cas12a protein was used to detect the target gene. The main parameters of the RPA-CRISPR/Cas12a detection system were optimized to determine the optimal reaction system. Result: RPA amplification primers and crRNA were successfully screened out, and the optimal reaction concentrations of three important parameters in the system, namely crRNA (40 uM), Cas12a (250 nM), and ssDNA (10 uM), were optimized. The genomic DNA detection sensitivity of Klebsiella pneumoniae can reach 10−5 ng/uL, and there is no cross-reaction with the common pathogenic bacteria in experimental animals. When this method is applied to the clinical detection of experimental animals, it has high sensitivity and specificity. Conclusion: The RPA-CRISRP/Cas12a detection method established in this study is simple to operate, real-time and rapid, low in cost and good in specificity, and can achieve rapid detection of Klebsiella pneumoniae infection in experimental animals.
文章引用:魏迅, 张曼, 彭丽娜. RPA-CRISRP/Cas12a技术快速检测实验动物感染肺炎克雷伯杆菌方法的建立及应用[J]. 生物医学, 2025, 15(4): 814-825. https://doi.org/10.12677/hjbm.2025.154087

参考文献

[1] 张诗渝, 黄克和. 肺炎克雷伯杆菌的分离鉴定及其对小鼠的致病性研究[D]: [硕士学位论文]. 南京: 南京农业大学, 2013.
[2] 魏杰, 林建伟, 付瑞, 等. 2009-2013年北京地区实验动物质量抽检结果分析[J]. 实验动物科学, 2014, 31(2): 1-6.
[3] 葛文平, 张旭, 高翔, 等. 我国商业化SPF级小鼠病原体污染分析[J]. 中国比较医学杂志, 2012, 22(3): 65-68.
[4] 李丹, 袁梦君, 王恬, 等. 鼠伤寒沙门氏菌CRISPR/Cas12a检测方法的建立与应用[J]. 食品安全质量检测学报, 2024, 15(12): 143-150.
[5] Craw, P. and Balachandran, W. (2012) Isothermal Nucleic Acid Amplification Technologies for Point-of-Care Diagnostics: A Critical Review. Lab on a Chip, 12, 2469-2486. [Google Scholar] [CrossRef] [PubMed]
[6] Hassan, M.M., Ranzoni, A. and Cooper, M.A. (2018) A Nanoparticle-Based Method for Culture-Free Bacterial DNA Enrichment from Whole Blood. Biosensors and Bioelectronics, 99, 150-155. [Google Scholar] [CrossRef] [PubMed]
[7] Chertow, D.S. (2018) Next-Generation Diagnostics with Crispr. Science, 360, 381-382. [Google Scholar] [CrossRef] [PubMed]
[8] Li, Y., Li, S., Wang, J. and Liu, G. (2019) Crispr/Cas Systems towards Next-Generation Biosensing. Trends in Biotechnology, 37, 730-743. [Google Scholar] [CrossRef] [PubMed]
[9] Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., et al. (2007) CRISPR Provides Acquired Resistance against Viruses in Prokaryotes. Science, 315, 1709-1712. [Google Scholar] [CrossRef] [PubMed]
[10] Xing, G., Shang, Y., Wang, X., Lin, H., Chen, S., Pu, Q., et al. (2023) Multiplexed Detection of Foodborne Pathogens Using One-Pot Crispr/Cas12a Combined with Recombinase Aided Amplification on a Finger-Actuated Microfluidic Biosensor. Biosensors and Bioelectronics, 220, Article ID: 114885. [Google Scholar] [CrossRef] [PubMed]
[11] Chen, M., Calin, G.A. and Meng, Q.H. (2014) Circulating MicroRNAs as Promising Tumor Biomarkers. In: Advances in Clinical Chemistry, Elsevier, 189-214. [Google Scholar] [CrossRef] [PubMed]
[12] Finotti, A., Fabbri, E., Lampronti, I., Gasparello, J., Borgatti, M. and Gambari, R. (2019) MicroRNAs and Long Non-Coding RNAs in Genetic Diseases. Molecular Diagnosis & Therapy, 23, 155-171. [Google Scholar] [CrossRef] [PubMed]
[13] Bonini, A., Poma, N., Vivaldi, F., Kirchhain, A., Salvo, P., Bottai, D., et al. (2021) Advances in Biosensing: The Crispr/Cas System as a New Powerful Tool for the Detection of Nucleic Acids. Journal of Pharmaceutical and Biomedical Analysis, 192, Article ID: 113645. [Google Scholar] [CrossRef] [PubMed]
[14] Swarts, D.C., van der Oost, J. and Jinek, M. (2017) Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by Crispr-Cas12a. Molecular Cell, 66, 221-233.e4. [Google Scholar] [CrossRef] [PubMed]
[15] Stella, S., Alcón, P. and Montoya, G. (2017) Structure of the Cpf1 Endonuclease R-Loop Complex after Target DNA Cleavage. Nature, 546, 559-563. [Google Scholar] [CrossRef] [PubMed]
[16] 张越华, 郑秀青. SPF级实验小鼠4种致病菌多重PCR方法的建立及优化[J] . 实验动物科学, 2018, 35(4): 49-55.
[17] 袁杰利, 主编. 肠道菌群与微生态调节剂[M]. 大连: 大连海事大学出版社, 1996: 1-19, 44-57.
[18] Chen, J.S., Ma, E., Harrington, L.B., et al. (2018) CRISPR-Cas12a Target Binding Unleashes Indiscriminate Single-Stranded DNase Activity. Science, 360, 436-439.
[19] 王雅轩, 朱晓雁, 苏建荣. CRISRP/Cas12a系统在病原体检测方面的研究进展[J]. 中国人兽共患病学报, 2021, 37(9): 839-844.
[20] 王紫怡, 黄迪, 徐志南, 等. CRISPR 核酸检测技术的研究进展[J]. 食品安全质量检测学报, 2021, 12(17): 6711-6719.